![ULTA](https://dbtnews.com/wp-content/uploads/2020/01/Image-59.png)
why Nektar Therapeutics [NKTR] is a Good Choice for Investors After New Price Target of $1.80
Nektar Therapeutics [NASDAQ: NKTR] closed the trading session at $1.24. The stocks have a year to date performance of 119.47 percent and weekly performance of 6.90 percent. The stock has been moved at 141.25 percent over the last six months. The stock has performed -10.14